News by Tag: Epoetin Alpha


Amgen to be the Worst Hit from US Biosimilar Erosion During 2011 - 2020
October 11, 2011
A new report from IMARC Group expects Amgen to lose brand sales worth US$ 8.4 Billion during 2010 and 2020 mainly as a result of biosimilar erosion.